Top Menu

DTC Perspectives Announces 2017 Advertising Awards Finalists

160420-dtc-1087

The leading forum for direct-to-consumer (DTC) advertising thought leaders honors a dynamic group of pharmaceutical companies and brands at the much-anticipated DTC National Advertising Awards. The awards are part of the 17th Annual DTC National Conference to be held April 5-7 in Boston. Sponsored by Health Monitor Network, the 2017 Advertising Awards will showcase the best marketing and advertising across 17 categories.

“The DTC National is exciting each year for us as a celebration of the creativity and effectiveness of DTC consumer promotion,” says Ken Freirich, President of Health Monitor Network. “As an entrepreneurial company developing creative solutions to facilitate patient and HCP dialogue, we are pleased to sponsor the awards and to recognize the many successes in the marketplace.”

The 2017 Ad Awards showcase exemplary work spanning multiple media and strategic categories. During the Advertising Awards Dinner held on April 6, Gold, Silver, and Bronze winners will be announced for all 17 categories. Be there in person to salute the winners or receive recognition for a job well done.

“We are proud to celebrate our 16th Annual DTC Ad Awards ceremony,” says Bob Ehrlich, CEO of DTC Perspectives. “The inclusion of new categories and more awards over the years is a reflection of the success of the industry as a whole. Congratulations to all of the finalists and we look forward to recognize innovation for years to come.”

To register for the DTC National Conference, order tickets to the Ad Awards dinner only, for more details about the event or Advertising Awards, visit www.dtc-national.com or contact the DTC Perspectives office at 770-302-6273.

View Ad Award Finalists Register

Celebrate with the Industry’s Best

DTC Perspectives offers reserved tables with seating for 10 at the DTC National Advertising Awards Dinner or the Top 25/Hall of Fame Awards Dinner. To reserve a table, click here.

Reserve Dinner Tables
admin
No comments yet.

Leave a Reply